India's Car Sales to Grow 3.5% Annually Till 2030: Moody's
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
India is set to remain a critical pillar of global automakers' strategies over the next decade, powered by a youthful workforce and growing income levels, according to a report released Tuesday by Moody's. The global credit agency underscored that while India's transition to electric vehicles (EVs) is underway, the shift will be gradual due to infrastructure shortcomings and supply chain constraints.
"India's car sales are expected to grow at a compound annual growth rate of 3.5 per cent—the highest in Asia—reaching around 5.1 million units by 2030," the report stated. A key factor driving this growth is India's relatively low vehicle penetration: just 44 cars per 1,000 people. Despite that, India already ranks as the third-largest auto market in the world by unit sales.
The competitive landscape in India remains intense. While homegrown manufacturers account for about a quarter of total car sales, more than 70 per cent of the market is dominated by Japanese, Korean, and Chinese automakers, many operating through joint ventures or subsidiaries. These players benefit from their extensive global product portfolios and established manufacturing capabilities.
Trade dynamics are also shifting. Moody's noted that India's ongoing trade talks and its recent agreement with the UK signal mounting pressure to liberalize a market long shielded by steep import tariffs. This could open new opportunities, and challenges, for both domestic and international players.
On the electrification front, progress is steady but far from rapid. Tata Motors and Hyundai are prioritizing battery electric vehicles, while Honda plans to ease in with plug-in hybrids. Automakers are expected to invest over $10 billion through 2030 to secure a competitive edge in the EV sector. However, these capital commitments are likely to strain their cash flows.
"The pace of battery electric vehicle adoption hinges on the development of a robust ecosystem, including nationwide charging infrastructure and reliable domestic battery supply chains," Moody's emphasized.
Even as global carmakers accelerate EV rollouts in China, Europe, and the US to meet emission targets, India's conventional vehicle market remains indispensable. Besides serving local demand, the country also functions as a vital export hub, reinforcing its strategic role in global automotive operations.
While EVs may struggle to reach profitability in many regions, Moody's concluded that India's demographic advantage and growing consumption will continue to fuel long-term demand for traditional vehicles.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Sugar Prices Tumble on an Expected Global Sugar Surplus
July NY world sugar #11 (SBN25) today is down -0.38 (-2.38%), and August London ICE white sugar #5 (SWQ25) is down -0.80 (-0.17%). Sugar prices today extended their three-month-long selloff, with NY sugar dropping to a 4-year nearest-futures low. Sugar prices have been under pressure over the past three months due to expectations of a global sugar surplus. On May 22, the USDA, in its biannual report, projected that global 2025/26 sugar production would increase by +4.7% y/y to a record 189.318 million metric tons (MMT), with a global sugar surplus of 41.188 MMT, up 7.5% year-over-year. Coffee Prices Extend 2-week Plunge as Frost Risks Recede in Brazil West African Cocoa Crop Optimism Weighs on Prices Sugar Prices Boosted by Strength in Crude Oil Prices Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! The outlook for higher sugar production in India, the world's second-largest producer, is bearish for prices. On June 2, India's National Federation of Cooperative Sugar Factories projected that India's 2025/26 sugar production would climb +19% y/y to 35 MMT, citing larger planted cane acreage. The outlook for abundant rainfall in India could lead to a bumper sugar crop, which is bearish for prices. On April 15, India's Ministry of Earth Sciences projected an above-normal monsoon this year, with total rainfall forecast to be 105% of the long-term average. India's monsoon season runs from June through September. Signs of larger global sugar output are negative for prices. On May 22, the USDA's Foreign Agricultural Service (FAS) predicted that Brazil's 2025/26 sugar production would rise +2.3% y/y to a record 44.7 MMT. Also, India's 2025/26 sugar production is projected to rise +25% y/y to 35.3 MMT, citing favorable monsoon rains and increased sugar acreage. In addition, Thailand's 2025/26 sugar production is expected to climb +2% y/y to 10.3 MMT. In a bearish factor, the Indian government said on January 20 that it would allow its sugar mills to export 1 MMT of sugar this season, easing the restrictions placed on sugar exports in 2023. India has restricted sugar exports since October 2023 to maintain adequate domestic supplies. India allowed mills to export only 6.1 MMT of sugar during the 2022/23 season to September 30, after allowing exports of a record 11.1 MMT in the previous season. However, the ISMA projects that India's 2024/25 sugar production will fall -17.5% y/y to a 5-year low of 26.2 MMT. Also, the ISMA reported last Monday that India's sugar production from Oct 1-May 15 was 25.74 MMT, down -17% from the same period last year. In addition, Indian Food Secretary Chopra said on May 1 that India's 2024/25 sugar exports may only total 800,000 MT, below earlier expectations of 1 MMT. The outlook for higher sugar production in Thailand is bearish for sugar prices. On May 2, Thailand's Office of the Cane and Sugar Board reported that Thailand's 2024/25 sugar production rose +14% y/y to 10.00 MMT. Thailand is the world's third-largest sugar producer and the second-largest exporter of sugar. A positive factor for sugar prices is the expected increase in sugar imports from Pakistan, following the Pakistani government's announcement last Friday that it plans to import 250,000 metric tons of raw sugar due to a disappointing sugarcane harvest. Sugar prices have some support from reduced sugar production in Brazil. Unica reported last Monday that the cumulative 2025/26 Brazil Center-South sugar output through May is down by -11.6% y/y to 6.954 MMT. Last month, Conab, Brazil's government crop forecasting agency, said 2024/25 Brazil sugar production fell -3.4% y/y to 44.118 MMT, citing lower sugarcane yields due to drought and excessive heat. The International Sugar Organization (ISO) raised its 2024/25 global sugar deficit forecast to a 9-year high of -5.47 MMT on May 15, up from a February forecast of -4.88 MMT. This indicates a tightening market following the 2023/24 global sugar surplus of 1.31 MMT. ISO also cut its 2024/25 global sugar production forecast to 174.8 MMT from a February forecast of 175.5 MMT. The USDA, in its bi-annual report released May 22, projected that global 2025/26 sugar production would climb +4.7% y/y to a record 189.318 MMT and that global 2025/26 human sugar consumption would increase +1.4% y/y to a record 177.921 MMT. The USDA also forecasted that 2025/26 global sugar ending stocks would climb +7.5% y/y to 41.188 MMT. On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Bloomberg
an hour ago
- Bloomberg
US Rare Earths Refiner Phoenix Tailings Eyes IPO Within 3 Years
US metals refiner Phoenix Tailings plans to pursue an initial public offering within three years after building out plants to produce rare earth elements to go into automobiles, medical devices and military equipment. 'That's our big target,' Chief Executive Officer Nick Myers said in a Monday interview. 'It's an aggressive goal, but I like to wake up and do aggressive things on a daily basis.'
Yahoo
an hour ago
- Yahoo
Novo Nordisk's $50 Obesity Shot Hits India -- The Drug War Just Got Real
Novo Nordisk (NYSE:NVO) is making a strategic move into one of the world's fastest-growing obesity markets by launching its blockbuster weight-loss drug Wegovy in India. Priced at just over $50 per week for the starting dose, the company is introducing all five dosage strengths under a locally tailored pricing strategy. At the high end, the 2.4 mg injection comes in at ?6,503.75still well below the U.S. price of $337.25, but nearly double the cost of Eli Lilly's (NYSE:LLY) Mounjaro, which entered the Indian market in March. Management emphasized that the rollout is focused on long-term chronic weight management and cardiovascular risk reduction, with supply being fully imported for now. Warning! GuruFocus has detected 1 Warning Sign with NVO. India presents a compelling growth opportunity. With over 80 million obese individualsprojected to reach 450 million by 2050the country is becoming a central front in the global battle against obesity and related diseases. Novo Nordisk's timing coincides with growing medical endorsements for semaglutide, including the recent recommendation by the American College of Cardiology for cardiovascular use. The company is working closely with distribution partners to ensure responsible access, particularly in urban centers where demand is expected to be strongest. In addition, Novo's India head highlighted efforts to prevent off-label cosmetic use and to collaborate with insurers and financing providers to improve affordability. While Wegovy's commercial push in India is just beginning, Novo is already thinking several steps ahead. Patent protections on semaglutide are set to expire in early Q2 2026, and Indian pharma companies like Sun Pharma, Cipla, and Dr. Reddy's are already preparing generics. Novo plans to respond by accelerating its next-gen pipeline, including obesity candidates like CagriSema and amycretin, which are currently in trials. As Wegovy gains traction, Novo's longer-term success in India could hinge not only on pricing and access, but also on its ability to stay ahead of the innovation curve. This article first appeared on GuruFocus.
